Mekrazym (Amylase, Lipase, Protease)

The three enzymes act on specific macronutrients: amylase hydrolyzes starches into simple sugars, lipase splits triglycerides into fatty acids and glycerol, and protease cleaves proteins into amino acids and peptides. Together they compensate for deficient pancreatic secretions, facilitating normal gastrointestinal digestion and nutrient uptake.

The appropriate dose of Mekrazym is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of enzyme deficiency, and dietary needs. No fixed regimen is provided here; the prescriber will tailor the amount to achieve optimal digestive support.

Limited clinical data are available on the use of Mekrazym in pregnancy or lactation. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before starting therapy.

To order Mekrazym, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mekrazym contains a combination of amylase, lipase, and protease similar to other pancreatic enzyme replacements such as Creon or Pancreaze. The primary differences lie in formulation, enzyme activity units, and excipients. Clinical effectiveness is comparable when dosed appropriately, but individual patient response and tolerability may vary, so selection should be guided by the prescriber.

Mekrazym should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the container tightly closed and out of direct sunlight. Do not use the product after the expiration date printed on the label.

Mekrazym is taken orally, usually with meals or snacks that contain food. The tablets or capsules should be swallowed whole with a sufficient amount of water, unless the prescribing information advises otherwise. Consistent timing with meals helps maximize the digestive benefit.

The most serious risks include severe allergic reactions such as anaphylaxis or angioedema, which require immediate medical attention. In rare cases, patients may experience severe abdominal pain indicating pancreatitis exacerbation. Any signs of difficulty breathing, swelling of the face or throat, or intense abdominal discomfort should prompt urgent evaluation.

Mekrazym should be avoided by individuals with a known hypersensitivity to any of its enzyme components or excipients. Patients with a history of severe allergic reactions to pancreatic enzyme preparations should not use this product without close medical supervision.